UB Paderborn / Katalog / Suche / in CDI

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758835918807339

2018

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

The lancet oncology, 2020-10, Vol.21 (10), p.1283-1295

2020

Link zum Volltext

Verfügbarkeit prüfen

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Breast Cancer: Basic and Clinical Research, 2015-01, Vol.2015 (2015), p.9-17

2015

Link zum Volltext

Verfügbarkeit prüfen

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.377-386

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS5-06: Prospective testing for PIK3CA/AKT1/PTEN alterations in tumor tissue from 1440 patients with advanced hormone receptor-positive HER2-negative breast cancer (HR+/HER2- BC) or triple-negative breast cancer (TNBC) screened for the IPATunity130 randomized phase 3 trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-06-PS5-06

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract GS3-04: Double-blind placebo (PBO)-controlled randomized phase III trial evaluating first-line ipatasertib (IPAT) combined with paclitaxel (PAC) for PIK3CA/AKT1/PTEN -altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC): primary results from IPATunity130 Cohort A

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.GS3-04-GS3-04

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD14-03: Molecular mechanism of ipatasertib (IPAT) and its combination with atezolizumab (atezo) in patients (pts) with locally advanced/metastatic triple-negative breast cancer (aTNBC)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD14-03-PD14-03

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world (RW) characteristics, treatment (tx) patterns, and overall survival (OS) in US patients (pts) with metastatic breast cancer (mBC) and CNS metastases (CNS mets)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1037-1037

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-10-23: Expression of PD-L1 is independent of PIK3CA/AKT1/PTEN alterations in triple-negative breast cancer (TNBC) and is not associated with response to ipatasertib (IPAT) plus paclitaxel (PAC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-10-23

2020

Link zum Volltext

Verfügbarkeit prüfen

IPATunity130: A pivotal randomized phase III trial evaluating ipatasertib (IPAT) + paclitaxel (PAC) for PIK3CA/AKT1/PTEN -altered advanced triple-negative (TN) or hormone receptor-positive HER2-negative (HR+/HER2–) breast cancer (BC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS1117-TPS1117

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT049: Phase Ib study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT049-CT049

2019

Link zum Volltext

Verfügbarkeit prüfen

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

The Journal of immunology (1950), 2011-03, Vol.186 (6), p.3401-3409

2011

Link zum Volltext

Verfügbarkeit prüfen

Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

Journal of organic chemistry, 2000-06, Vol.65 (12), p.3733-3737

2000

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-11-08: Eribulin/cyclophosphamide (ErC) versus docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in locally advanced HER2-negative breast cancer: A randomized phase II trial of the Sarah Cannon Research Institute

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-11-08

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of sequencing weekly paclitaxel (T) and dose-dense doxorubicin/cyclophosphamide (DDAC) on tolerability and relative dose intensity (RDI) in breast cancer (BC) patients (pts) receiving neoadjuvant chemotherapy (NAC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1048-1048

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2686: Anti-tumor effects of a folate-immunoglobulin conjugate are enhanced by cytokine treatment in vitro and in vivo

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2686-2686

2011

Link zum Volltext

Verfügbarkeit prüfen

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Breast cancer : basic and clinical research, 2015-04, Vol.2015 (9), p.9-17

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer

Breast cancer research and treatment, 2009-09, Vol.117 (1), p.83

2009

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis of multiple myeloma : Apoptosis in lymphoid neoplasia

International journal of hematology, 2004, Vol.80 (3), p.224-231

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere

Current science (Bangalore), 1990-10, Vol.59 (20), p.988-991

1990

Link zum Volltext

Verfügbarkeit prüfen

A MODEL STUDY OF EFFECT OF ELECTRON TEMPERATURE ENHANCEMENTS ON D-AND E-REGION ELECTRON DENSITIES

Current science (Bangalore), 1989, Vol.58 (21), p.1194-1195

1989

Link zum Volltext

Verfügbarkeit prüfen

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere: Challenging areas in earth and atmospheric sciences

Current science (Bangalore), 1990, Vol.59 (20), p.988-991

1990

Link zum Volltext

Verfügbarkeit prüfen

ChemInform Abstract: Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

ChemInform, 2000-10, Vol.31 (43), p.no-no

2000

Link zum Volltext

Verfügbarkeit prüfen

Effective hybrid video denoising and blending framework for Internet of Remote Things (IoRT) environments

Automatika, 2024-04, Vol.65 (2), p.510-522

2024

Link zum Volltext

Verfügbarkeit prüfen

Sustainable Technical Debt-Aware Computing Model for Virtual Machine Migration (TD4VM) in IaaS Cloud

Wireless communications and mobile computing, 2022-04, Vol.2022, p.1-12

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Abstract PS5-06: Prospective testing for PIK3CA/AKT1/PTEN alterations in tumor tissue from 1440 patients with advanced hormone receptor-positive HER2-negative breast cancer (HR+/HER2- BC) or triple-negative breast cancer (TNBC) screened for the IPATunity130 randomized phase 3 trial

Abstract PD14-03: Molecular mechanism of ipatasertib (IPAT) and its combination with atezolizumab (atezo) in patients (pts) with locally advanced/metastatic triple-negative breast cancer (aTNBC)

Real-world (RW) characteristics, treatment (tx) patterns, and overall survival (OS) in US patients (pts) with metastatic breast cancer (mBC) and CNS metastases (CNS mets)

Abstract P4-10-23: Expression of PD-L1 is independent of PIK3CA/AKT1/PTEN alterations in triple-negative breast cancer (TNBC) and is not associated with response to ipatasertib (IPAT) plus paclitaxel (PAC)

IPATunity130: A pivotal randomized phase III trial evaluating ipatasertib (IPAT) + paclitaxel (PAC) for PIK3CA/AKT1/PTEN -altered advanced triple-negative (TN) or hormone receptor-positive HER2-negative (HR+/HER2–) breast cancer (BC)

Abstract CT049: Phase Ib study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

Abstract P3-11-08: Eribulin/cyclophosphamide (ErC) versus docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in locally advanced HER2-negative breast cancer: A randomized phase II trial of the Sarah Cannon Research Institute

Impact of sequencing weekly paclitaxel (T) and dose-dense doxorubicin/cyclophosphamide (DDAC) on tolerability and relative dose intensity (RDI) in breast cancer (BC) patients (pts) receiving neoadjuvant chemotherapy (NAC)

Abstract 2686: Anti-tumor effects of a folate-immunoglobulin conjugate are enhanced by cytokine treatment in vitro and in vivo

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer

Apoptosis of multiple myeloma : Apoptosis in lymphoid neoplasia

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere

A MODEL STUDY OF EFFECT OF ELECTRON TEMPERATURE ENHANCEMENTS ON D-AND E-REGION ELECTRON DENSITIES

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere: Challenging areas in earth and atmospheric sciences

ChemInform Abstract: Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

Effective hybrid video denoising and blending framework for Internet of Remote Things (IoRT) environments

Sustainable Technical Debt-Aware Computing Model for Virtual Machine Migration (TD4VM) in IaaS Cloud

Aktive Filter

Suchergebnisse filtern